Global Prostate Cancer Clinical Trial Pipeline Highlights Report 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Global Prostate Cancer Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.

Prostate Cancer Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Prostate Cancer market. It covers emerging therapies for Prostate Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Prostate Cancer pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Prostate Cancer pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Prostate Cancer pipeline products by the company.

Short-term Launch Highlights:

Find out which Prostate Cancer pipeline products will be launched in the US and Ex-US till 2024.

Summary:

  • Prostate Cancer phase 3 clinical trial pipeline products
  • Prostate Cancer phase 2 clinical trial pipeline products
  • Prostate Cancer phase 1 clinical trial pipeline products
  • Prostate Cancer preclinical research pipeline products
  • Prostate Cancer discovery stage pipeline products
  • Prostate Cancer pipeline products short-term launch highlights

Key Topics Covered:

1. Prostate Cancer Pipeline by Stages

2. Prostate Cancer Phase 3 Clinical Trial Insights

3. Prostate Cancer Phase 2 Clinical Trial Insights

4. Prostate Cancer Phase 1 Clinical Trial Insights

5. Prostate Cancer Preclinical Research Insights

6. Prostate Cancer Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/kymca6

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Prostate Cancer Drugs, Clinical Trials

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Prostate Cancer Drugs, Clinical Trials